- Article
Isoliquiritigen Enhances the Antitumour Activity and Decreases the Genotoxic Effect of Cyclophosphamide
- Hong Zhao,
- Xuan Yuan,
- Defang Li,
- Hongmei Chen,
- Jiangtao Jiang,
- Zhiping Wang,
- Xiling Sun and
- Qiusheng Zheng
The aim of this study was to evaluate the antitumour activities and genotoxic effects of isoliquiritigenin (ISL) combined with cyclophosphamide (CP) in vitro and in vivo. U14 cells were treated with either of ISL (5–25 μg/mL) or CP (0.25–1.25 mg/mL)...